These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 33648921)

  • 1. Variations in IL-22, IL-27 and IL-35 serum levels in untreated and treated hepatitis C patients.
    Taghinejad A; Barani S; Gholijani N; Ghandehari F; Khansalar S; Asadipour M; Davarpanah M; Fattahi M; Kalantar K
    Eur Cytokine Netw; 2020 Dec; 31(4):134-139. PubMed ID: 33648921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation Between Serum Cytokines, Interferons, and Liver Functions in Hepatitis C Virus Patients.
    Afify M; Hamza AH; Alomari RA
    J Interferon Cytokine Res; 2017 Jan; 37(1):32-38. PubMed ID: 27726476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-18 in Blood Serum of Hepatitis C Patients Might be of Predictive Value for Individual Outcomes.
    Asadipour M; Fazeli P; Zohouri M; Bemani P; Mohebbiniya M; Khansalar S; Fattahi MR; Kalantar K
    Infect Disord Drug Targets; 2021; 21(3):389-393. PubMed ID: 32634083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood and hepatic Toll-like receptor 7 expression and interferon lambda 1 levels in chronic hepatitis C: Relation to virus replication and liver injury.
    El Aggan H; Farahat N; El Deeb N; Zeid A; El-Shendidi A
    Microb Pathog; 2019 Jun; 131():65-74. PubMed ID: 30926417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotype-related variations in proinflammatory and regulatory cytokine levels in treated and treatment-naive HCV-infected patients.
    Baharlou R; Romani B; Kiani SJ; Sadeghi K; Shadmand E; Fazel H; Jalilian FA; Kord E; Yaghoubi S; Nikmanesh Y; Ahmadi Vasmehjani A
    Med Microbiol Immunol; 2018 Feb; 207(1):65-74. PubMed ID: 29147974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of lncRNA GAS5, lncRNA HEIH, lncRNA BISPR and its mRNA BST2 as serum innovative non-invasive biomarkers: Recent insights into Egyptian patients with hepatitis C virus type 4.
    El Samaloty NM; Shabayek MI; Ghait RS; El-Maraghy SA; Rizk SM; El-Sawalhi MM
    World J Gastroenterol; 2020 Jan; 26(2):168-183. PubMed ID: 31988583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.
    Sousa GM; Oliveira IS; Andrade LJ; Sousa-Atta ML; Paraná R; Atta AM
    Cytokine; 2012 Oct; 60(1):138-42. PubMed ID: 22748467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the role of HCV Plus-/Minus strand RNA, IFN-γ and IL-29 in relapse outcome in patients infected with HCV.
    Alborzi AM; Bamdad T; Davoodian P; Hashempoor T; Nejatizadeh AA; Moayedi J
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):173-81. PubMed ID: 26342113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interleukin 4 and interleukin 10 levels in patients with chronic hepatitis C virus infection.
    Reiser M; Marousis CG; Nelson DR; Lauer G; González-Peralta RP; Davis GL; Lau JY
    J Hepatol; 1997 Mar; 26(3):471-8. PubMed ID: 9075651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of elevated serum interferon- inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels.
    Itoh Y; Morita A; Nishioji K; Narumi S; Toyama T; Daimon Y; Nakamura H; Kirishima T; Okanoue T
    J Viral Hepat; 2001 Sep; 8(5):341-8. PubMed ID: 11555191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of IL-10, IL-15 and soluble tumour necrosis factor-alpha (TNF-alpha) receptors in type C chronic liver disease.
    Kakumu S; Okumura A; Ishikawa T; Yano M; Enomoto A; Nishimura H; Yoshioka K; Yoshika Y
    Clin Exp Immunol; 1997 Sep; 109(3):458-63. PubMed ID: 9328122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sofosbuvir-based treatment is safe and effective in Indian hepatitis C patients on maintenance haemodialysis: A retrospective study.
    Akhil MS; Kirushnan B; Martin M; Arumugam K; Ganesh Prasad NK; Ravichandran R
    Nephrology (Carlton); 2018 May; 23(5):446-452. PubMed ID: 28339162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis.
    Comarmond C; Garrido M; Pol S; Desbois AC; Costopoulos M; Le Garff-Tavernier M; Si Ahmed SN; Alric L; Fontaine H; Bellier B; Maciejewski A; Rosenzwajg M; Klatzmann D; Musset L; Poynard T; Cacoub P; Saadoun D
    Gastroenterology; 2017 Jun; 152(8):2052-2062.e2. PubMed ID: 28274850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation, outcome, and response to therapy among patients with acute exacerbation of chronic hepatitis C.
    Sagnelli E; Pisaturo M; Stanzione M; Messina V; Alessio L; Sagnelli C; Starace M; Pasquale G; Coppola N
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1174-1180.e11. PubMed ID: 23591280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection.
    Sumida Y; Nakashima T; Yoh T; Nakajima Y; Ishikawa H; Mitsuyoshi H; Sakamoto Y; Okanoue T; Kashima K; Nakamura H; Yodoi J
    J Hepatol; 2000 Oct; 33(4):616-22. PubMed ID: 11059866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine deaminase activity in serum of patients with hepatitis -- a useful tool in monitoring clinical status.
    Kaya S; Cetin ES; Aridogan BC; Arikan S; Demirci M
    J Microbiol Immunol Infect; 2007 Aug; 40(4):288-92. PubMed ID: 17712462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased serum aminotransferase activity in patients with chronic renal failure: impact on the detection of viral hepatitis.
    Fabrizi F; Lunghi G; Finazzi S; Colucci P; Pagano A; Ponticelli C; Locatelli F
    Am J Kidney Dis; 2001 Nov; 38(5):1009-15. PubMed ID: 11684554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Closing Chapter: Hepatitis C Genotype 3 Elimination in Liver Transplant; Sofosbuvir/Daclatasvir in a Hard-to-Treat Population.
    Teegen EM; Globke B; Schott E; Pratschke J; Eurich D
    Exp Clin Transplant; 2018 Feb; 16(1):61-67. PubMed ID: 29137590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients.
    Mölleken C; Ahrens M; Schlosser A; Dietz J; Eisenacher M; Meyer HE; Schmiegel W; Holmskov U; Sarrazin C; Sorensen GL; Sitek B; Bracht T
    Clin Mol Hepatol; 2019 Mar; 25(1):42-51. PubMed ID: 30449076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.